Pulmonary Mucormycosis in a Poorly Controlled Diabetic Patient

Area of Science:

• Mycology
• Infectious Diseases
• Pulmonology

Background:

• Mucormycosis is a severe, life-threatening fungal infection.
• It primarily affects immunocompromised individuals.
• Commonly presents with rhino-orbito-cerebral or pulmonary involvement.

Observation:

• A 49-year-old patient presented with diabetic ketoacidosis and Influenza B pneumonia.
• The pneumonia was unresponsive to initial treatment.
• Pulmonary mucormycosis was diagnosed as the underlying cause.

Findings:

• Accurate diagnosis of pulmonary mucormycosis was achieved.
• The patient received appropriate treatment with isavuconazole.
• The patient experienced a favorable clinical evolution.

Implications:

• This case highlights the importance of considering mucormycosis in immunocompromised patients with refractory infections.
• Timely and accurate diagnosis is critical for effective management.
• Isavuconazole is an effective treatment option for pulmonary mucormycosis.